Who makes ELI-002 2P?

ELI-002 2P is developed by Elicio Therapeutics.

What are the side effects of ELI-002 2P?

Common side effects include Anaemia, Headache, Abdominal pain, Nausea, Fatigue, Malaise.

Last reviewed 2026-04-20 · How we verify

ELI-002 2P

Elicio Therapeutics · Phase 1 active Small molecule Quality 20/100

At a glance

Generic name	ELI-002 2P
Sponsor	Elicio Therapeutics
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

Anaemia
Headache
Abdominal pain
Nausea
Fatigue
Malaise
Contusion
Electrolyte imbalance
Rash
Lymphadenopathy
Sinus bradycardia
Dermoid cyst

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

ELI-002 2P CI brief — competitive landscape report
ELI-002 2P updates RSS · CI watch RSS
Elicio Therapeutics portfolio CI